Description
・アルツハイマー病新薬「レカネマブ」承認へ。どんな薬なの？ ・アルツハイマー病の鍵となる「アミロイドベータ」とは。 ・18ヵ月の臨床試験の結果を詳しい数字で解説！ ・承認後の課題、先に承認された米国での状況は？ ・知りたい！新薬が承認される際の基本スタンスとは。 ・一般生活者として、このニュースをどう捉えるか。老年科専門医の言葉。
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast